Delivery Order SPE2DB20D3103-SPE2DB25FP6L2
- Not listed
- The Defense Logistics Agency awarded a $1,340.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a non-set-aside competitive award, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559241095 Adacel TDAP syringes (0.5 mL). The $14,298.10 firm-fixed-price delivery order has a period of performance through December 2, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,277.20 order is for the delivery of ADACEL TDAP vaccine vials to a location in Conshohocken, Pennsylvania by March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,496.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is to supply 4558171879 ADACEL TDAP VIAL 0.5ML, with a completion date of August 23, 2022. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, including the military. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.23 firm-fixed-price contract is for the supply of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a period of performance through February 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,842,229 units of the ADACEL TDAP VIAL 0.5ML pharmaceutical product. The $3,831.60 delivery order has a performance period through March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,729.10 firm fixed-price contract is for the supply of ADACEL TDAP syringes, a pediatric vaccine. The contract has a completion date of March 29, 2023 and does not have any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $15,202.36 firm fixed price delivery order is for the supply of ADACEL TDAP SYRINGE 5S, a pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of ADACEL TDAP 0.5ML syringes, with a ceiling value of $12,056.00 and a completion date of December 14, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) and classified as a for-profit organization. The contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for ADACEL TDAP SYRINGE 0.5ML, with a firm fixed price of $26,800.00 and a period of performance through June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6L2Delivery Order
The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, syringes, and other medical commodities to support military healthcare programs worldwide. The ADACEL TDAP vaccine delivery fulfills a critical immunization need within the federal military medical supply chain, consistent with AmerisourceBergen's established portfolio of vaccine and specialty medication deliveries across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.6k | 7/25/25 |